Mathematical model can speed up Alzheimer’s drug development
Drug Discovery World
NOVEMBER 29, 2023
Mapping individual Alzheimer’s disease progression The team’s model relies on clinical biomarkers for Alzheimer’s disease, including fluid markers for the amyloid protein that is responsible for plaque build-up in the brain, cognitive decline scores from pencil-and-paper testing, and MRI brain images.
52 
Let's personalize your content